Burning Rock Biotech Limited (BNR) News
Follow Burning Rock Biotech Limited (BNR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Brenntag Global Partnership With DSM-Firmenich For Byphar Powered By Biond™
Brenntag SE XETR:BNR
NEWS | Sep 29, 2026, 08:06 AM UTC
L
Brenntag Enters Distribution Agreement With Symrise In Brazil
Brenntag SE XETR:BNR
NEWS | Sep 28, 2026, 01:07 PM UTC
L
Burning Rock Biotech 2Q revenue $134.8M
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re
EQUITY | Sep 10, 2026, 11:29 AM UTC
L
Burning Rock Biotech reports 2Q loss of $18.4M
EQUITY | Sep 10, 2026, 11:17 AM UTC
L
BNR - Burning Rock Reports Second Quarter 2026 Financial Results
BNR - Burning Rock Reports Second Quarter 2026 Financial Results
EARNINGS | Sep 10, 2026, 11:17 AM UTC
L
Ifo says German chemical industry mood turns positive after four years
Ifo reports German chemical industry mood turned positive for the first time in four years.
EQUITY | Aug 28, 2026, 06:00 AM UTC
L
BNR announces exclusive distribution agreement with Zeus Hygia Life Sciences
BNR announced an exclusive distribution agreement with Zeus Hygia Life Sciences.
EQUITY | Aug 27, 2026, 08:28 AM UTC
M
DAX opens 0.40% higher as Fresenius leads gainers
The DAX Index is up 105 points, or 0.40%, on Thursday, with Fresenius, Qiagen NV and Commerzbank among the top gainers while Brenntag, BASF and Hannover Rueck lag.
EQUITY | Aug 13, 2026, 07:31 AM UTC
L
Burning Rock Biotech shares are trading higher after the company announced its founder, chairman and CEO, Yusheng Han, has purchased 73,141
Burning Rock Biotech shares are trading higher after the company announced its founder, chairman and CEO, Yusheng Han, has purchased 73,141 ADSs for $618,217.72.
EQUITY | Jul 02, 2026, 06:33 PM UTC
H
Burning Rock Biotech Founding Chairman And CEO Mr. Yusheng Han Buys 73,141 BNR ADSs On Open Market For ~$618.2K
As of the date of this press release, combined with 72,733 ADSs purchased in the last two post-earnings trading windows, Mr. Han has purchased an aggregate of 145,874 of the Company’s ADSs for US$1,976,542.90 across thre
EARNINGS | Jul 02, 2026, 11:22 AM UTC